ATE239074T1 - Transduktion von menschlichen hämatopoiestischen stammzellen - Google Patents

Transduktion von menschlichen hämatopoiestischen stammzellen

Info

Publication number
ATE239074T1
ATE239074T1 AT97904089T AT97904089T ATE239074T1 AT E239074 T1 ATE239074 T1 AT E239074T1 AT 97904089 T AT97904089 T AT 97904089T AT 97904089 T AT97904089 T AT 97904089T AT E239074 T1 ATE239074 T1 AT E239074T1
Authority
AT
Austria
Prior art keywords
human
stem cells
hematopioestic
transduction
cells
Prior art date
Application number
AT97904089T
Other languages
English (en)
Inventor
Craig T Jordan
Steve Hardy
Original Assignee
Cell Genesys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell Genesys Inc filed Critical Cell Genesys Inc
Application granted granted Critical
Publication of ATE239074T1 publication Critical patent/ATE239074T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0647Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT97904089T 1996-02-05 1997-02-05 Transduktion von menschlichen hämatopoiestischen stammzellen ATE239074T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US1117296P 1996-02-05 1996-02-05
US1121996P 1996-02-06 1996-02-06
US2168396P 1996-07-12 1996-07-12
PCT/US1997/001476 WO1997028269A1 (en) 1996-02-05 1997-02-05 Transduced human hematopoietic stem cells

Publications (1)

Publication Number Publication Date
ATE239074T1 true ATE239074T1 (de) 2003-05-15

Family

ID=27359380

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97904089T ATE239074T1 (de) 1996-02-05 1997-02-05 Transduktion von menschlichen hämatopoiestischen stammzellen

Country Status (7)

Country Link
US (1) US20020061293A1 (de)
EP (1) EP0879294B1 (de)
JP (1) JP2000505284A (de)
AT (1) ATE239074T1 (de)
AU (1) AU717974B2 (de)
DE (1) DE69721493D1 (de)
WO (1) WO1997028269A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9818432D0 (en) 1998-08-24 1998-10-21 Bioline Limited Thermostable DNA Polymerase
JP4833443B2 (ja) * 2001-06-27 2011-12-07 旭化成株式会社 造血幹細胞の採取方法
EP3356520B1 (de) 2015-10-02 2022-03-23 The U.S.A. as represented by the Secretary, Department of Health and Human Services Lentivirales protein übertragungssystem zum rna-vermittelten genomeditieren

Also Published As

Publication number Publication date
DE69721493D1 (de) 2003-06-05
US20020061293A1 (en) 2002-05-23
JP2000505284A (ja) 2000-05-09
EP0879294B1 (de) 2003-05-02
AU717974B2 (en) 2000-04-06
WO1997028269A1 (en) 1997-08-07
EP0879294A1 (de) 1998-11-25
AU1847597A (en) 1997-08-22

Similar Documents

Publication Publication Date Title
DE69733247D1 (de) Humanisiertes grünes-fluoreszenzprotein und methoden
DE69534588D1 (de) Protocadherin-proteine und verwendungen davon
DE69739480D1 (de) Menschliche hämatopoietische stamm und vorläuferzellantigen und methoden zu dessen verwendung
ATE238020T1 (de) Hautpflegezusammensetzungen und methode für die verbesserung des hautaussehens
DE69413039D1 (de) Prostaglandin rezeptor fp und kodierende dns
ATE402698T1 (de) Verwendung von ppar-gamma aktivatoren zur behandlung von hautkrankheiten
DK0670735T3 (da) Perifisering af hæmotopoietiske stamceller.
TR199902426T2 (xx) Bitki b�ceklerinin kontrol�.
TR199800812T2 (xx) Uzun-dayanan kozmetik �r�nlerinin performans�n�n geli�tirilmesi i�in y�ntemler ve bile�imler.
DE69426033D1 (de) Für die alpha-1e untereinheit des menschlichen kalziumkanals kodierende dna
DE69630955T2 (de) Immortalisierung bzw. desimmortalisierung von zellen
ID23374A (id) Halogenopirimidin
DE69432470D1 (de) Dna kodierend für prostaglandin rezeptor ip
PT938308E (pt) Agentes antiparasitarios
GR3029483T3 (en) Antibodies against t-cells as therapeutics
AU2003226127A1 (en) Antibody libraries
ES2026206T3 (es) Procedimiento para mejorar la expresion de proteina de eucariota.
DE69405230D1 (de) Prostaglandinrezeptor ep1 kodierende dna
DE69721493D1 (de) Transduktion von menschlichen hämatopoiestischen stammzellen
DK0705277T3 (da) Prostaglandinreceptor EP3 og DNA kodende denne
AR009819A1 (es) Inhibidores de la proteasa proteinicos estabilizados y sus variantes
DE69619808D1 (de) Chimäre msp und daf proteine mit einem telloberflächenlokalisierendem domän
ATE254659T1 (de) Mikroorganismen, ihre herstellung und verwendung
PT870015E (pt) Novas xilanases os genes que as codificam e as suas utilizacoes
ES8505540A1 (es) Procedimiento para la obtencion de alcoxiaril-alcanoles

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties